Medical Devices Startups
6,372 companies tagged Medical Devices, with their investors and founders.
NodeAI is a healthcare-focused company that builds algorithms and runs clinical trials with the aim of raising the standard of medical care. It appears to operate at the intersection of artificial intelligence and clinical medicine.
2 investors
Best NOMOS designs radiation therapy planning and delivery systems for medical professionals treating cancer patients. The company specializes in innovations for intensity-modulated radiation therapy (IMRT) and image-guided radiation therapy (IGRT), serving oncology centers globally with external beam and brachytherapy solutions.
2 investors
Nosis develops a platform for receptor-targeted delivery of RNA therapeutics to specific cell types, addressing a key bottleneck in RNA drug development. The company aims to reduce the cost and timeline of bringing new RNA medicines to market.
2 investors
Nostopharma develops targeted nanodelivery technology and advanced molecular interventions for bone and soft tissue disorders, using precision medicine approaches to repurpose existing drugs. The company serves clinicians treating patients with conditions like heterotopic ossification and cartilage damage.
2 investors
Novai applies advanced molecular and computational approaches to eye disease, supporting clinicians and researchers in translating scientific findings into patient treatment options.
2 investors
NovalGen is a clinical-stage biotechnology company developing multi-specific biologics for oncology, autoimmune, haematological, and metabolic disorders using its proprietary AutoRegulation platform technology.
2 investors
Novocuff is a medical device company developing the Novocuff Cervical Control System, an investigational device aimed at improving outcomes for pregnancies affected by preterm prelabor rupture of membranes (PPROM) or cervical shortening. It focuses on maternal and infant health related to preterm birth complications.
2 investors
Novocure develops Tumor Treating Fields therapy for treating aggressive forms of cancer. The company focuses on patient-centered innovation in oncology.
2 investors
A specialty pharmaceutical company focused on developing and commercializing novel therapeutics for central nervous system conditions, serving patients and healthcare providers.
2 investors
Nusano produces medical radioisotopes for use in theranostic compounds and cancer treatment applications. The company serves the healthcare and oncology sectors by making radioisotopes available for targeted radiopharmaceutical therapies.
2 investors
NXgenPort is developing a smart implantable chemotherapy port that integrates optical sensing and machine learning to monitor blood cell dynamics and other physiological changes in vivo, paired with a digital health platform for data analysis. It targets oncology care teams and cancer patients, aiming to detect treatment complications like infection and neutropenia early for remote patient monitoring.
2 investors
NxStage provides home dialysis products and support for people with chronic kidney disease and end-stage renal disease, including home hemodialysis and peritoneal dialysis. It offers educational resources and patient support services to help patients manage treatment at home.
2 investors
Nymbl provides cloud-based software for orthotic and prosthetic (O&P), custom rehabilitation technology (CRT), and durable medical equipment (DME) practices to manage operations, billing, and patient care. The platform helps healthcare providers streamline administrative tasks, improve billing efficiency, and grow their operations.
2 investors
Oblenio Bio develops LBL-051, a tri-specific T-cell engager therapy targeting BCMA, CD19, and CD3 for treating refractory autoimmune diseases through B-cell and plasma cell depletion. The company aims to achieve long-term drug-free remission in autoimmune disease patients.
2 investors
Octozi provides AI-powered automation for clinical data workflows including cleaning, review, reconciliation, reporting, and operations in clinical trials. The platform serves pharmaceutical sponsors and clinical development teams seeking to reduce manual data handling and errors.
2 investors
OK2StandUP develops smart activity monitoring systems with AI-based alerts for healthcare organizations to prevent falls and support caregiver awareness in patient care settings. The solution serves hospitals, rehabilitation facilities, memory care facilities, and other care environments for older adults.
2 investors
Omeros is a publicly traded biotech company developing a diverse pipeline of first-in-class small-molecule and antibody therapeutics targeting unmet medical needs across multiple therapeutic areas and indications. The company pursues orphan, large-market, and novel therapeutic programs through vertically integrated drug development.
2 investors
Omnix Medical is a biopharmaceutical company founded in 2015 that develops novel antibiotic agents to treat infections caused by drug-resistant bacteria. Its lead compound, OMN6, is a first-in-class antimicrobial in Phase II clinical trials targeting drug-resistant Acinetobacter baumannii infections.
2 investors
Oncimmune is a biomarker discovery and diagnostics company specializing in proteomics and bioinformatics technologies for autoimmunity, cancer research, and clinical drug development. The company serves pharmaceutical, biotech, and academic partners by developing diagnostic tools and biomarkers for various phases of clinical development.
2 investors
Oncoinvent is a biotechnology company focused on drug development and commercialization in the pharmaceutical sector. The company is led by executives with extensive experience in biotech management, clinical programs, and global pharmaceutical commercialization.
2 investors
OncoHost develops the PROphet platform, a precision medicine diagnostic tool combining proteomics, bioinformatics, and machine learning to help oncologists predict patient response to cancer therapies and select optimal treatment. The company serves clinicians and cancer patients worldwide with biomarker-driven insights to overcome treatment resistance.
2 investors
OncoPatch develops a non-invasive medical patch that delivers low-energy beta therapy to treat non-melanoma skin cancers, including basal and squamous cell carcinomas. The single-application treatment is administered in a physician's office and targets cancer cells while sparing healthy tissue.
2 investors
Oncorena is a Swedish pharmaceutical company developing a breakthrough treatment for metastatic renal cancer based on the drug candidate ONC175 (orellanine). The company targets an orphan drug indication with clinical development underway.
2 investors
OncoRes Medical develops an intraoperative imaging technology that combines optical coherence tomography (OCT) and elastography to give surgeons real-time assessment of tissue microstructure at a resolution comparable to histology. The medical device company works with breast cancer surgeons and pathologists and is developing its technology for surgical use.
2 investors